Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TMP001 in Relapsing-remitting Multiple Sclerosis: A Multicentre Open, Baseline-controlled Phase IIa Clinical Trial

NCT02686788 is registered in ClinicalTrials.gov with Dr. Frank Behrens as lead sponsor.

NCT NCT02686788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02686788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TMP001 in Relapsing-remitting Multiple Sclerosis: A Multicentre Open, Baseline-controlled Phase IIa Clinical Trial
Lead sponsor
Dr. Frank Behrens
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2015
Completion date
April 30, 2018
Enrollment
9 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

remitting-relapsing multiple sclerosis